{"id":62468,"date":"2026-11-14T01:45:45","date_gmt":"2026-11-13T16:45:45","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/renal-cancer-drug-market-straits\/"},"modified":"2026-11-14T01:52:19","modified_gmt":"2026-11-13T16:52:19","slug":"renal-cancer-drug-market-straits","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/renal-cancer-drug-market-straits\/","title":{"rendered":"\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u304a\u3088\u3073\u30c8\u30ec\u30f3\u30c9\u5206\u6790\u30ec\u30dd\u30fc\u30c8\uff1a\u30bf\u30a4\u30d7\u5225\uff08\u900f\u660e\u7d30\u80de\u3001\u4e73\u982d\u72b6\u3001\u8272\u7d20\u7d30\u80de\u3001\u816b\u760d\u7d30\u80de\u3001\u96c6\u5408\u7ba1\u3001\u305d\u306e\u4ed6\uff09\u3001\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff08\u6a19\u7684\u7642\u6cd5\u3001\u514d\u75ab\u7642\u6cd5\uff09\u3001\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff08\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u3001mTOR\u963b\u5bb3\u5264\u3001\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u3001\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09\uff09\u3001\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff08\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af\u3001\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc\u3001\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc\u3001\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u3001\u305d\u306e\u4ed6\uff09\u304a\u3088\u3073\u5730\u57df\u5225\uff08\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\uff09\u4e88\u6e2c\u30012026-2034\u5e74"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/11\/renal-cancer-drug-market-5275.webp\" alt=\"Market Image 1\" style=\"max-width:100%; height:auto; margin-bottom: 20px;\" \/><br \/><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/11\/renal-cancer-drug-market-forecast-values.webp\" alt=\"Market Image 2\" style=\"max-width:100%; height:auto; margin-bottom: 20px;\" \/><\/p>\n<h2>Report Coverage &amp; Table of Contents<\/h2>\n<h3>\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/h3>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u30c8\u30ec\u30f3\u30c9\u3092\u5305\u62ec\u7684\u306b\u5206\u6790\u3057\u30012026\u5e74\u304b\u30892034\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u814e\u764c\u306f\u3001\u4e16\u754c\u4e2d\u3067\u5897\u52a0\u3057\u3066\u3044\u308b\u764c\u306e\u4e00\u7a2e\u3067\u3042\u308a\u3001\u6cbb\u7642\u85ac\u306e\u9700\u8981\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u814e\u764c\u6cbb\u7642\u85ac\u306e\u30bf\u30a4\u30d7\u3001\u6cbb\u7642\u30af\u30e9\u30b9\u3001\u85ac\u7406\u30af\u30e9\u30b9\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u3001\u5730\u57df\u5225\u306b\u5e02\u5834\u3092\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n<h3>\u7814\u7a76\u7bc4\u56f2\u3068\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<\/h3>\n<p>\u672c\u7814\u7a76\u306f\u3001\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u3092\u4ee5\u4e0b\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u3051\u3066\u5206\u6790\u3057\u307e\u3059\uff1a<\/p>\n<ul>\n<li>\u30bf\u30a4\u30d7\uff08\u660e\u7d30\u80de\u3001\u4e73\u982d\u72b6\u3001\u8272\u7d20\u7d30\u80de\u3001\u816b\u760d\u7d30\u80de\u3001\u96c6\u5408\u7ba1\u3001\u305d\u306e\u4ed6\uff09<\/li>\n<li>\u6cbb\u7642\u30af\u30e9\u30b9\uff08\u6a19\u7684\u7642\u6cd5\u3001\u514d\u75ab\u7642\u6cd5\uff09<\/li>\n<li>\u85ac\u7406\u30af\u30e9\u30b9\uff08\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u3001mTOR\u963b\u5bb3\u5264\u3001\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u3001\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09\uff09<\/li>\n<li>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\uff08\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af\u3001\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc\u3001\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc\u3001\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u3001\u305d\u306e\u4ed6\uff09<\/li>\n<li>\u5730\u57df\uff08\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\uff09<\/li>\n<\/ul>\n<h3>\u7814\u7a76\u76ee\u7684<\/h3>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306e\u76ee\u7684\u306f\u3001\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3092\u628a\u63e1\u3057\u3001\u6295\u8cc7\u6a5f\u4f1a\u3092\u7279\u5b9a\u3059\u308b\u3053\u3068\u3067\u3059\u3002\u307e\u305f\u3001\u5404\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u696d\u754c\u95a2\u4fc2\u8005\u304c\u6226\u7565\u7684\u306a\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u305f\u3081\u306e\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5236\u9650\u4e8b\u9805\u3068\u4eee\u5b9a<\/h3>\n<p>\u672c\u7814\u7a76\u306b\u306f\u3001\u30c7\u30fc\u30bf\u306e\u53ce\u96c6\u3084\u5206\u6790\u306b\u304a\u3051\u308b\u5236\u9650\u304c\u5b58\u5728\u3057\u307e\u3059\u3002\u7279\u306b\u3001\u5730\u57df\u3054\u3068\u306e\u30c7\u30fc\u30bf\u306e\u53ef\u7528\u6027\u3084\u3001\u7279\u5b9a\u306e\u6cbb\u7642\u85ac\u306b\u95a2\u3059\u308b\u60c5\u5831\u304c\u4e0d\u5b8c\u5168\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u5236\u9650\u3092\u8003\u616e\u3057\u3001\u4eee\u5b9a\u306b\u57fa\u3065\u3044\u3066\u5206\u6790\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u7bc4\u56f2\u3068\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u3001\u4e0a\u8a18\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u57fa\u3065\u3044\u3066\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3001\u5404\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u52d5\u5411\u3084\u6210\u9577\u8981\u56e0\u304c\u8003\u616e\u3055\u308c\u307e\u3059\u3002<\/p>\n<h3>\u901a\u8ca8\u3068\u4fa1\u683c\u8a2d\u5b9a\u306e\u8003\u616e<\/h3>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u7c73\u30c9\u30eb\uff08USD\uff09\u3092\u57fa\u6e96\u901a\u8ca8\u3068\u3057\u3066\u4f7f\u7528\u3057\u3001\u4fa1\u683c\u8a2d\u5b9a\u306f2022\u5e74\u306e\u5e02\u5834\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u3044\u3066\u3044\u307e\u3059\u3002\u70ba\u66ff\u30ec\u30fc\u30c8\u306e\u5909\u52d5\u3082\u8003\u616e\u3055\u308c\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u6a5f\u4f1a\u8a55\u4fa1<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u6a5f\u4f1a\u3092\u8a55\u4fa1\u3057\u3001\u7279\u306b\u65b0\u8208\u5730\u57df\u3084\u65b0\u8208\u4f01\u696d\u306e\u52d5\u5411\u306b\u6ce8\u76ee\u3057\u307e\u3059\u3002<\/p>\n<h3>\u65b0\u8208\u5730\u57df\/\u56fd<\/h3>\n<p>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3084\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u5730\u57df\u306a\u3069\u306e\u65b0\u8208\u5e02\u5834\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u306e\u9700\u8981\u304c\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u4f01\u696d\u306f\u65b0\u305f\u306a\u5e02\u5834\u6a5f\u4f1a\u3092\u6a21\u7d22\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u65b0\u8208\u4f01\u696d<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u306f\u3001\u65b0\u305f\u306b\u53c2\u5165\u3059\u308b\u4f01\u696d\u304c\u5897\u3048\u3066\u304a\u308a\u3001\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u3084\u88fd\u54c1\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u306e\u52d5\u5411\u3092\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n<h3>\u65b0\u8208\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\/\u30a8\u30f3\u30c9\u30e6\u30fc\u30b9<\/h3>\n<p>\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u3084\u6280\u8853\u306e\u9032\u6b69\u306b\u3088\u308a\u3001\u814e\u764c\u6cbb\u7642\u85ac\u306e\u4f7f\u7528\u304c\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u3001\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc\u3084\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc\u3067\u306e\u5229\u7528\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u30c8\u30ec\u30f3\u30c9<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30c8\u30ec\u30f3\u30c9\u3092\u7279\u5b9a\u3057\u3001\u3053\u308c\u3089\u306e\u30c8\u30ec\u30f3\u30c9\u304c\u5e02\u5834\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n<h3>\u30c9\u30e9\u30a4\u30d0\u30fc<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u8981\u56e0\u3092\u7279\u5b9a\u3057\u3001\u3053\u308c\u3089\u306e\u8981\u56e0\u304c\u5e02\u5834\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u8a55\u4fa1\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u8b66\u544a\u8981\u56e0<\/h3>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u59a8\u3052\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u30ea\u30b9\u30af\u8981\u56e0\u3092\u5206\u6790\u3057\u3001\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u5bfe\u3059\u308b\u6226\u7565\u3092\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u30de\u30af\u30ed\u7d4c\u6e08\u6307\u6a19<\/h3>\n<p>\u7d4c\u6e08\u5168\u4f53\u306e\u52d5\u5411\u304c\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u8a55\u4fa1\u3057\u3001\u30de\u30af\u30ed\u7d4c\u6e08\u6307\u6a19\u3068\u5e02\u5834\u306e\u76f8\u95a2\u95a2\u4fc2\u3092\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5730\u653f\u5b66\u7684\u5f71\u97ff<\/h3>\n<p>\u5730\u653f\u5b66\u7684\u306a\u8981\u56e0\u304c\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u8003\u5bdf\u3057\u3001\u7279\u306b\u8cbf\u6613\u653f\u7b56\u3084\u898f\u5236\u306e\u5909\u5316\u306b\u6ce8\u76ee\u3057\u307e\u3059\u3002<\/p>\n<h3>\u6280\u8853\u8981\u56e0<\/h3>\n<p>\u65b0\u3057\u3044\u6280\u8853\u306e\u9032\u6b69\u304c\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u53ca\u307c\u3059\u5f71\u97ff\u3092\u5206\u6790\u3057\u3001\u7279\u306b\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u3084\u88fd\u54c1\u306e\u958b\u767a\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u8a55\u4fa1<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u5168\u4f53\u7684\u306a\u8a55\u4fa1\u3092\u884c\u3044\u3001\u5404\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u898f\u6a21\u3084\u6210\u9577\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790<\/h3>\n<p>\u7af6\u4e89\u74b0\u5883\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306b\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u3092\u5b9f\u65bd\u3057\u3001\u696d\u754c\u306e\u7af6\u4e89\u529b\u3092\u8a55\u4fa1\u3057\u307e\u3059\u3002<\/p>\n<h3>\u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u5206\u6790<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u3092\u5206\u6790\u3057\u3001\u5404\u6bb5\u968e\u3067\u306e\u4fa1\u5024\u5275\u9020\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u7406\u89e3\u3057\u307e\u3059\u3002<\/p>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u5206\u6790<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u30012022\u5e74\u304b\u30892034\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5c0e\u5165<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u5168\u4f53\u50cf\u3092\u628a\u63e1\u3059\u308b\u305f\u3081\u306e\u5c0e\u5165\u90e8\u3068\u3057\u3066\u3001\u696d\u754c\u306e\u80cc\u666f\u3084\u5e02\u5834\u306e\u91cd\u8981\u6027\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002<\/p>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u306e\u5e02\u5834\u898f\u6a21\u3092\u30bf\u30a4\u30d7\u5225\u306b\u5206\u6790\u3057\u3001\u4e88\u6e2c\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u660e\u7d30\u80de<\/li>\n<li>\u4e73\u982d\u72b6<\/li>\n<li>\u8272\u7d20\u7d30\u80de<\/li>\n<li>\u816b\u760d\u7d30\u80de<\/li>\n<li>\u96c6\u5408\u7ba1<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<p>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3092\u5206\u6790\u3057\u3001\u4e88\u6e2c\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u6a19\u7684\u7642\u6cd5<\/li>\n<li>\u514d\u75ab\u7642\u6cd5<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<p>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3092\u5206\u6790\u3057\u3001\u4e88\u6e2c\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/li>\n<li>mTOR\u963b\u5bb3\u5264<\/li>\n<li>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/li>\n<li>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<p>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3092\u5206\u6790\u3057\u3001\u4e88\u6e2c\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af<\/li>\n<li>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u5317\u7c73\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u5206\u6790<\/h3>\n<p>\u5317\u7c73\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3092\u5206\u6790\u3057\u3001\u5404\u30bf\u30a4\u30d7\u3001\u6cbb\u7642\u30af\u30e9\u30b9\u3001\u85ac\u7406\u30af\u30e9\u30b9\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5c0e\u5165<\/h3>\n<p>\u5317\u7c73\u5e02\u5834\u306e\u80cc\u666f\u3092\u8aac\u660e\u3057\u3001\u7279\u306b\u814e\u764c\u6cbb\u7642\u85ac\u306e\u9700\u8981\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u660e\u7d30\u80de<\/li>\n<li>\u4e73\u982d\u72b6<\/li>\n<li>\u8272\u7d20\u7d30\u80de<\/li>\n<li>\u816b\u760d\u7d30\u80de<\/li>\n<li>\u96c6\u5408\u7ba1<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u6a19\u7684\u7642\u6cd5<\/li>\n<li>\u514d\u75ab\u7642\u6cd5<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/li>\n<li>mTOR\u963b\u5bb3\u5264<\/li>\n<li>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/li>\n<li>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af<\/li>\n<li>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u30a2\u30e1\u30ea\u30ab\u5408\u8846\u56fd<\/h3>\n<p>\u30a2\u30e1\u30ea\u30ab\u5408\u8846\u56fd\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u8a73\u7d30\u306a\u5206\u6790\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5c0e\u5165<\/h3>\n<p>\u30a2\u30e1\u30ea\u30ab\u5e02\u5834\u306e\u80cc\u666f\u3092\u8aac\u660e\u3057\u3001\u7279\u306b\u814e\u764c\u6cbb\u7642\u85ac\u306e\u9700\u8981\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u660e\u7d30\u80de<\/li>\n<li>\u4e73\u982d\u72b6<\/li>\n<li>\u8272\u7d20\u7d30\u80de<\/li>\n<li>\u816b\u760d\u7d30\u80de<\/li>\n<li>\u96c6\u5408\u7ba1<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u6a19\u7684\u7642\u6cd5<\/li>\n<li>\u514d\u75ab\u7642\u6cd5<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/li>\n<li>mTOR\u963b\u5bb3\u5264<\/li>\n<li>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/li>\n<li>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af<\/li>\n<li>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u30ab\u30ca\u30c0<\/h3>\n<p>\u30ab\u30ca\u30c0\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u8a73\u7d30\u306a\u5206\u6790\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5c0e\u5165<\/h3>\n<p>\u30ab\u30ca\u30c0\u5e02\u5834\u306e\u80cc\u666f\u3092\u8aac\u660e\u3057\u3001\u7279\u306b\u814e\u764c\u6cbb\u7642\u85ac\u306e\u9700\u8981\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u660e\u7d30\u80de<\/li>\n<li>\u4e73\u982d\u72b6<\/li>\n<li>\u8272\u7d20\u7d30\u80de<\/li>\n<li>\u816b\u760d\u7d30\u80de<\/li>\n<li>\u96c6\u5408\u7ba1<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u6a19\u7684\u7642\u6cd5<\/li>\n<li>\u514d\u75ab\u7642\u6cd5<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/li>\n<li>mTOR\u963b\u5bb3\u5264<\/li>\n<li>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/li>\n<li>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af<\/li>\n<li>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u5206\u6790<\/h3>\n<p>\u30e8\u30fc\u30ed\u30c3\u30d1\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3092\u5206\u6790\u3057\u3001\u5404\u30bf\u30a4\u30d7\u3001\u6cbb\u7642\u30af\u30e9\u30b9\u3001\u85ac\u7406\u30af\u30e9\u30b9\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5c0e\u5165<\/h3>\n<p>\u30e8\u30fc\u30ed\u30c3\u30d1\u5e02\u5834\u306e\u80cc\u666f\u3092\u8aac\u660e\u3057\u3001\u7279\u306b\u814e\u764c\u6cbb\u7642\u85ac\u306e\u9700\u8981\u306b\u3064\u3044\u3066\u8003\u5bdf\u3057\u307e\u3059\u3002<\/p>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u660e\u7d30\u80de<\/li>\n<li>\u4e73\u982d\u72b6<\/li>\n<li>\u8272\u7d20\u7d30\u80de<\/li>\n<li>\u816b\u760d\u7d30\u80de<\/li>\n<li>\u96c6\u5408\u7ba1<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u6a19\u7684\u7642\u6cd5<\/li>\n<li>\u514d\u75ab\u7642\u6cd5<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/li>\n<li>mTOR\u963b\u5bb3\u5264<\/li>\n<li>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/li>\n<li>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff092022-2034\uff08\u767e\u4e07\u7c73\u30c9\u30eb\/\u5358\u4f4d\uff09<\/h3>\n<ul>\n<li>\u75c5\u9662\u30fb\u30af\u30ea\u30cb\u30c3\u30af<\/li>\n<li>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/li>\n<li>\u305d\u306e\u4ed6<\/li>\n<\/ul>\n<p><h\n\n\n\n<h3>\u306f\u3058\u3081\u306b<\/p>\n<p>\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u814e\u764c\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u304a\u308a\u3001\u69d8\u3005\u306a\u85ac\u5264\u304c\u958b\u767a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u672c\u30ac\u30a4\u30c9\u3067\u306f\u3001\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u30c8\u30ec\u30f3\u30c9\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u30012022\u5e74\u304b\u30892034\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<h3>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h3>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h3>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h3>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h3>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h3>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h3>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30c9\u30a4\u30c4<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30c9\u30a4\u30c4\u306e\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u5730\u57df\u306e\u533b\u7642\u6280\u8853\u306e\u9032\u6b69\u3068\u60a3\u8005\u306e\u9700\u8981\u306b\u652f\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h4>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h4>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30d5\u30e9\u30f3\u30b9<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30d5\u30e9\u30f3\u30b9\u306b\u304a\u3051\u308b\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u5c0e\u5165\u3068\u3068\u3082\u306b\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h4>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h4>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30b9\u30da\u30a4\u30f3<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30b9\u30da\u30a4\u30f3\u306e\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u306e\u767a\u5c55\u3068\u5171\u306b\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h4>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h4>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30a4\u30bf\u30ea\u30a2<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30a4\u30bf\u30ea\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u60a3\u8005\u306e\u30cb\u30fc\u30ba\u306b\u5fdc\u3058\u305f\u6cbb\u7642\u6cd5\u306e\u591a\u69d8\u5316\u304c\u9032\u3093\u3067\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h4>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h4>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30ed\u30b7\u30a2<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30ed\u30b7\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u533b\u7642\u6280\u8853\u306e\u5411\u4e0a\u3068\u3068\u3082\u306b\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h4>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264 (Angiogenesis Inhibitors)<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264 (mTOR Inhibitors)<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53 (Monoclonal Antibodies)<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5 (IL-2) (Cytokine Immunotherapy)<\/strong><\/li>\n<\/ul>\n<h4>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af (Hospitals and Clinics)<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc (Ambulatory Surgical Centers)<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc (Diagnostic Centers)<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc (Research Centers)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h3>\u30ce\u30eb\u30c7\u30a3\u30c3\u30af<\/h3>\n<h4>\u306f\u3058\u3081\u306b<\/h4>\n<p>\u30ce\u30eb\u30c7\u30a3\u30c3\u30af\u5730\u57df\u306b\u304a\u3051\u308b\u814e\u764c\u85ac\u5e02\u5834\u306f\u3001\u533b\u7642\u30a2\u30af\u30bb\u30b9\u306e\u5411\u4e0a\u3068\u5171\u306b\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4>\u30bf\u30a4\u30d7\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30af\u30ea\u30a2\u30bb\u30eb\u816b\u760d (Clear Cell)<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u816b\u760d (Papillary)<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u816b\u760d (Chromophobe)<\/strong><\/li>\n<li><strong>\u817a\u816b\u760d (Oncocytic)<\/strong><\/li>\n<li><strong>\u96c6\u675f\u7ba1\u816b\u760d (Collecting Duct)<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6 (Others)<\/strong><\/li>\n<\/ul>\n<h4>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb\/\u30e6\u30cb\u30c3\u30c8)<\/h4>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5 (Targeted Therapy)<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5 (Immuno Therapy)<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u3053\u306e\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u8a73\u3057\u304f\u8aac\u660e\u3057\u307e\u3059\u3002\u4ee5\u4e0b\u306e4\u3064\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u306b\u5206\u985e\u3055\u308c\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u3001\u4ee5\u4e0b\u306e\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u306b\u57fa\u3065\u3044\u3066\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u304c\u884c\u308f\u308c\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u30d9\u30cd\u30eb\u30af\u30b9<\/h3>\n<p>\u30d9\u30cd\u30eb\u30af\u30b9\u5730\u57df\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002\u3053\u306e\u5730\u57df\u306f\u3001\u533b\u7642\u30a4\u30f3\u30d5\u30e9\u306e\u5145\u5b9f\u3068\u9ad8\u3044\u533b\u7642\u9700\u8981\u304c\u7279\u5fb4\u3067\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u4ee5\u4e0b\u306b\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u6b27\u5dde\u305d\u306e\u4ed6\u5730\u57df<\/h3>\n<p>\u3053\u306e\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001\u6b27\u5dde\u305d\u306e\u4ed6\u5730\u57df\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u6b27\u5dde\u305d\u306e\u4ed6\u5730\u57df\u306e\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>APAC\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u5206\u6790<\/h3>\n<p>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u3053\u306e\u5730\u57df\u306f\u6025\u6210\u9577\u3057\u3066\u304a\u308a\u3001\u533b\u7642\u306e\u9032\u5c55\u304c\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>APAC\u5730\u57df\u306e\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>APAC\u5730\u57df\u306b\u304a\u3051\u308b\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001APAC\u5730\u57df\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>APAC\u5730\u57df\u306b\u304a\u3051\u308b\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u4e2d\u56fd<\/h3>\n<p>\u4e2d\u56fd\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u4e2d\u56fd\u306f\u814e\u764c\u306e\u767a\u75c7\u7387\u304c\u9ad8\u304f\u3001\u6cbb\u7642\u85ac\u306e\u9700\u8981\u304c\u6025\u5897\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u4e2d\u56fd\u306e\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u4e2d\u56fd\u306b\u304a\u3051\u308b\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u4e2d\u56fd\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u4e2d\u56fd\u306b\u304a\u3051\u308b\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u97d3\u56fd<\/h3>\n<p>\u97d3\u56fd\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u97d3\u56fd\u306f\u5148\u9032\u7684\u306a\u533b\u7642\u6280\u8853\u3092\u6301\u3061\u3001\u9ad8\u3044\u533b\u7642\u30b5\u30fc\u30d3\u30b9\u306e\u9700\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u97d3\u56fd\u306e\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u97d3\u56fd\u306b\u304a\u3051\u308b\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u97d3\u56fd\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<li><strong>\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u97d3\u56fd\u306b\u304a\u3051\u308b\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u75c5\u9662\u304a\u3088\u3073\u30af\u30ea\u30cb\u30c3\u30af<\/strong><\/li>\n<li><strong>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u7814\u7a76\u30bb\u30f3\u30bf\u30fc<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u65e5\u672c<\/h3>\n<p>\u65e5\u672c\u306b\u304a\u3051\u308b\u814e\u764c\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u52d5\u5411\u3068\u4e88\u6e2c\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u65e5\u672c\u306f\u9ad8\u3044\u533b\u7642\u6280\u8853\u3068\u7814\u7a76\u958b\u767a\u306e\u4e2d\u5fc3\u5730\u3067\u3059\u3002<\/p>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u30bf\u30a4\u30d7\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u65e5\u672c\u306e\u814e\u764c\u306e\u30bf\u30a4\u30d7\u5225\u306b\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u660e\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u4e73\u982d\u72b6\u764c<\/strong><\/li>\n<li><strong>\u8272\u7d20\u6027\u764c<\/strong><\/li>\n<li><strong>\u816b\u760d\u7d30\u80de\u764c<\/strong><\/li>\n<li><strong>\u96c6\u5408\u7ba1\u764c<\/strong><\/li>\n<li><strong>\u305d\u306e\u4ed6<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u6cbb\u7642\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u65e5\u672c\u306b\u304a\u3051\u308b\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<\/strong><\/li>\n<li><strong>\u514d\u75ab\u7642\u6cd5<\/strong><\/li>\n<\/ul>\n<h3>\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\uff1a\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225 2022-2034 (\u767e\u4e07\u7c73\u30c9\u30eb \/ \u30e6\u30cb\u30c3\u30c8)<\/h3>\n<p>\u518d\u5ea6\u3001\u65e5\u672c\u306e\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u3092\u793a\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>mTOR\u963b\u5bb3\u5264<\/strong><\/li>\n<li><strong>\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/strong><\/li>\n<\/ul>\n<h3>Cytokine Immunotherapy (IL-2)<\/h3>\n<p>Cytokine immunotherapy, particularly Interleukin-2 (IL-2), plays a crucial role in the treatment of renal cancer. This section provides insights into the market size and forecasts by end-users from 2022 to 2034.<\/p>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> This segment is expected to show significant growth due to the increasing number of patients diagnosed with renal cancer.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> These centers are gaining popularity for outpatient procedures, contributing to the growth of IL-2 treatments.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> The demand for effective diagnostic tools is rising, which will influence the use of IL-2 therapies.<\/li>\n<li><strong>Research Centers:<\/strong> Ongoing research in cytokine therapies will drive the market forward.<\/li>\n<li><strong>Others:<\/strong> This includes various healthcare facilities that administer IL-2 treatments.<\/li>\n<\/ul>\n<h3>India<\/h3>\n<p>India&#8217;s renal cancer drug market is poised for growth, driven by increasing incidences of renal cancer and advancements in treatment options.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> The most common type of renal cell carcinoma, with significant market share.<\/li>\n<li><strong>Papillary:<\/strong> This subtype is also prevalent, contributing to market growth.<\/li>\n<li><strong>Chromophobe:<\/strong> Although less common, it still represents a portion of the market.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging research may increase awareness and treatment options.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but critical to consider in market forecasts.<\/li>\n<li><strong>Others:<\/strong> Includes less common types of renal cancer.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> A growing segment due to advancements in personalized medicine.<\/li>\n<li><strong>Immuno Therapy:<\/strong> Increasingly popular, especially IL-2 based treatments.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Critical for renal cancer treatment.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Important class for managing cancer cell growth.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A strong focus in the market.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A key player in the immunotherapy landscape.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Major contributors to IL-2 therapy adoption.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Facilitate outpatient treatment options.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Critical for early detection and treatment initiation.<\/li>\n<li><strong>Research Centers:<\/strong> Push the boundaries of IL-2 research.<\/li>\n<li><strong>Others:<\/strong> Various facilities involved in patient care.<\/li>\n<\/ul>\n<h3>Australia<\/h3>\n<p>Australia&#8217;s renal cancer drug market is characterized by advanced healthcare infrastructure and increasing awareness of renal cancer treatments.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> Dominates the market due to its prevalence.<\/li>\n<li><strong>Papillary:<\/strong> Contributing to growth alongside clear cell.<\/li>\n<li><strong>Chromophobe:<\/strong> Recognized but less prevalent.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest in treatment options.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but significant in treatment discussions.<\/li>\n<li><strong>Others:<\/strong> Remaining types of renal cancer.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> Increasingly recognized for its effectiveness.<\/li>\n<li><strong>Immuno Therapy:<\/strong> IL-2 therapies gaining traction.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Essential for treatment strategies.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Recognized for their role in cancer management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A focal point in the therapeutic landscape.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> Significant market segment.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Primary providers of IL-2 treatment.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Popular for outpatient procedures.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Key for early diagnosis.<\/li>\n<li><strong>Research Centers:<\/strong> Driving innovations in IL-2.<\/li>\n<li><strong>Others:<\/strong> Various healthcare institutions.<\/li>\n<\/ul>\n<h3>Singapore<\/h3>\n<p>Singapore&#8217;s healthcare system is advanced, leading to a growing market for renal cancer drugs, including IL-2 therapies.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> The leading type in treatment protocols.<\/li>\n<li><strong>Papillary:<\/strong> Also prevalent in the market.<\/li>\n<li><strong>Chromophobe:<\/strong> Less common but important.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but significant.<\/li>\n<li><strong>Others:<\/strong> Other renal cancer types.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> A major focus in treatment.<\/li>\n<li><strong>Immuno Therapy:<\/strong> IL-2 therapies gaining ground.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Key treatment option.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Important for patient management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> Significant class in the market.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A prominent segment.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Major treatment facilities.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Increasingly popular for outpatient care.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Essential for early detection.<\/li>\n<li><strong>Research Centers:<\/strong> Innovating treatment options.<\/li>\n<li><strong>Others:<\/strong> Various healthcare providers.<\/li>\n<\/ul>\n<h3>Taiwan<\/h3>\n<p>Taiwan&#8217;s renal cancer drug market is expanding, driven by healthcare advancements and increasing cancer awareness.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> The most common type in Taiwan.<\/li>\n<li><strong>Papillary:<\/strong> Also significant in the market.<\/li>\n<li><strong>Chromophobe:<\/strong> Less common but noteworthy.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but important.<\/li>\n<li><strong>Others:<\/strong> Other types of renal cancer.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> Increasingly recognized.<\/li>\n<li><strong>Immuno Therapy:<\/strong> Growing interest in IL-2.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Critical for treatment.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Important in management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A significant focus.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A key market segment.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Primary providers of IL-2 therapy.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Popular for outpatient procedures.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Essential for early diagnosis.<\/li>\n<li><strong>Research Centers:<\/strong> Pioneering IL-2 research.<\/li>\n<li><strong>Others:<\/strong> Various healthcare facilities.<\/li>\n<\/ul>\n<h3>South East Asia<\/h3>\n<p>The South East Asia region is witnessing significant growth in the renal cancer drug market, driven by increasing cancer incidences and healthcare advancements.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> The leading type in treatment protocols.<\/li>\n<li><strong>Papillary:<\/strong> Contributes to market growth.<\/li>\n<li><strong>Chromophobe:<\/strong> Recognized but less prevalent.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest in treatment options.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but significant in treatment discussions.<\/li>\n<li><strong>Others:<\/strong> Other renal cancer types.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> Increasingly recognized for its effectiveness.<\/li>\n<li><strong>Immuno Therapy:<\/strong> IL-2 therapies gaining traction.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Essential for treatment strategies.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Recognized for their role in cancer management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A focal point in the therapeutic landscape.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A significant market segment.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Major contributors to IL-2 therapy adoption.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Facilitate outpatient treatment options.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Key for early detection and treatment initiation.<\/li>\n<li><strong>Research Centers:<\/strong> Push the boundaries of IL-2 research.<\/li>\n<li><strong>Others:<\/strong> Various healthcare institutions involved in patient care.<\/li>\n<\/ul>\n<h3>Rest of Asia-Pacific<\/h3>\n<p>The Rest of Asia-Pacific region is experiencing growth in the renal cancer drug market, fueled by advancements in healthcare and increasing awareness of treatment options.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> The most prevalent type of renal cancer.<\/li>\n<li><strong>Papillary:<\/strong> Also significant in the market.<\/li>\n<li><strong>Chromophobe:<\/strong> Less common but noteworthy.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but important.<\/li>\n<li><strong>Others:<\/strong> Other types of renal cancer.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> Increasingly recognized.<\/li>\n<li><strong>Immuno Therapy:<\/strong> Growing interest in IL-2 therapies.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Critical for treatment.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Important in management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A significant focus in the market.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A prominent segment.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By End-Users 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Hospitals and Clinics:<\/strong> Primary providers of IL-2 treatment.<\/li>\n<li><strong>Ambulatory Surgical Centers:<\/strong> Increasingly popular for outpatient care.<\/li>\n<li><strong>Diagnostic Centers:<\/strong> Essential for early diagnosis.<\/li>\n<li><strong>Research Centers:<\/strong> Pioneering research in IL-2 therapies.<\/li>\n<li><strong>Others:<\/strong> Various healthcare facilities involved in treatment.<\/li>\n<\/ul>\n<h3>Middle East and Africa Renal Cancer Drug Market Size Analysis<\/h3>\n<p>The Middle East and Africa region is witnessing growth in the renal cancer drug market, driven by increasing incidences of renal cancer and advancements in treatment options.<\/p>\n<h4>Market Size &#038; Forecast By Type 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Clear Cell:<\/strong> Dominates the market due to its prevalence.<\/li>\n<li><strong>Papillary:<\/strong> Contributing to growth alongside clear cell.<\/li>\n<li><strong>Chromophobe:<\/strong> Recognized but less prevalent.<\/li>\n<li><strong>Oncocytic:<\/strong> Emerging interest in treatment options.<\/li>\n<li><strong>Collecting Duct:<\/strong> Rare but significant in treatment discussions.<\/li>\n<li><strong>Others:<\/strong> Other renal cancer types.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Therapeutic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Targeted Therapy:<\/strong> Increasingly recognized for its effectiveness.<\/li>\n<li><strong>Immuno Therapy:<\/strong> IL-2 therapies gaining traction.<\/li>\n<\/ul>\n<h4>Market Size &#038; Forecast By Pharmacologic Class 2022-2034 (USD MILLION\/ Units)<\/h4>\n<ul>\n<li><strong>Angiogenesis Inhibitors:<\/strong> Essential for treatment strategies.<\/li>\n<li><strong>mTOR Inhibitors:<\/strong> Recognized for their role in cancer management.<\/li>\n<li><strong>Monoclonal Antibodies:<\/strong> A focal point in the therapeutic landscape.<\/li>\n<li><strong>Cytokine Immunotherapy (IL-2):<\/strong> A significant market segment.<\/li>\n<p><\/\n\n\n\n<h2>List of Tables<\/h2>\n<div class=\"mrai-list-of-tables\">\n<ul style=\"list-style-type: none; padding-left: 0; line-height: 1.8;\">\n<li><strong>\u88681\uff1a<\/strong>\u5730\u57df\u5225\u306e\u4e16\u754c\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88682\uff1a<\/strong>\u30bf\u30a4\u30d7\u5225\u306e\u4e16\u754c\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88683\uff1a<\/strong>\u6cbb\u7642\u30af\u30e9\u30b9\u5225\u306e\u4e16\u754c\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88684\uff1a<\/strong>\u85ac\u7406\u30af\u30e9\u30b9\u5225\u306e\u4e16\u754c\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88685\uff1a<\/strong>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\u306e\u4e16\u754c\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88686\uff1a<\/strong>\u5317\u7c73\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u56fd\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88687\uff1a<\/strong>\u5317\u7c73\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88688\uff1a<\/strong>\u5317\u7c73\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u88689\uff1a<\/strong>\u5317\u7c73\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886810\uff1a<\/strong>\u5317\u7c73\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886811\uff1a<\/strong>\u7c73\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886812\uff1a<\/strong>\u7c73\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886813\uff1a<\/strong>\u7c73\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886814\uff1a<\/strong>\u7c73\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886815\uff1a<\/strong>\u30ab\u30ca\u30c0\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886816\uff1a<\/strong>\u30ab\u30ca\u30c0\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886817\uff1a<\/strong>\u30ab\u30ca\u30c0\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886818\uff1a<\/strong>\u30ab\u30ca\u30c0\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886819\uff1a<\/strong>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u56fd\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886820\uff1a<\/strong>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886821\uff1a<\/strong>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886822\uff1a<\/strong>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886823\uff1a<\/strong>\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886824\uff1a<\/strong>\u82f1\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886825\uff1a<\/strong>\u82f1\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886826\uff1a<\/strong>\u82f1\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886827\uff1a<\/strong>\u82f1\u56fd\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886828\uff1a<\/strong>\u30c9\u30a4\u30c4\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886829\uff1a<\/strong>\u30c9\u30a4\u30c4\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886830\uff1a<\/strong>\u30c9\u30a4\u30c4\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886831\uff1a<\/strong>\u30c9\u30a4\u30c4\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886832\uff1a<\/strong>\u30d5\u30e9\u30f3\u30b9\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886833\uff1a<\/strong>\u30d5\u30e9\u30f3\u30b9\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886834\uff1a<\/strong>\u30d5\u30e9\u30f3\u30b9\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886835\uff1a<\/strong>\u30d5\u30e9\u30f3\u30b9\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886836\uff1a<\/strong>\u30b9\u30da\u30a4\u30f3\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886837\uff1a<\/strong>\u30b9\u30da\u30a4\u30f3\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886838\uff1a<\/strong>\u30b9\u30da\u30a4\u30f3\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886839\uff1a<\/strong>\u30b9\u30da\u30a4\u30f3\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886840\uff1a<\/strong>\u30a4\u30bf\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886841\uff1a<\/strong>\u30a4\u30bf\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886842\uff1a<\/strong>\u30a4\u30bf\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u85ac\u7406\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886843\uff1a<\/strong>\u30a4\u30bf\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886844\uff1a<\/strong>\u30ed\u30b7\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u30bf\u30a4\u30d7\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886845\uff1a<\/strong>\u30ed\u30b7\u30a2\u814e\u764c\u85ac\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c &#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225 &#8211; 2022-2034 (USD\u5341\u5104)<\/li>\n<li><strong>\u886846\uff1a<\/strong>\u30ed\u30b7\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886847\uff1a<\/strong>\u30ed\u30b7\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886848\uff1a<\/strong>\u5317\u6b27\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886849\uff1a<\/strong>\u5317\u6b27\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886850\uff1a<\/strong>\u5317\u6b27\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886851\uff1a<\/strong>\u5317\u6b27\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886852\uff1a<\/strong>\u30d9\u30cd\u30eb\u30af\u30b9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886853\uff1a<\/strong>\u30d9\u30cd\u30eb\u30af\u30b9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886854\uff1a<\/strong>\u30d9\u30cd\u30eb\u30af\u30b9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886855\uff1a<\/strong>\u30d9\u30cd\u30eb\u30af\u30b9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886856\uff1a<\/strong>\u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886857\uff1a<\/strong>\u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886858\uff1a<\/strong>\u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886859\uff1a<\/strong>\u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886860\uff1a<\/strong>APAC\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u56fd\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886861\uff1a<\/strong>APAC\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886862\uff1a<\/strong>APAC\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886863\uff1a<\/strong>APAC\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886864\uff1a<\/strong>APAC\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886865\uff1a<\/strong>\u4e2d\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886866\uff1a<\/strong>\u4e2d\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886867\uff1a<\/strong>\u4e2d\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886868\uff1a<\/strong>\u4e2d\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886869\uff1a<\/strong>\u97d3\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886870\uff1a<\/strong>\u97d3\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886871\uff1a<\/strong>\u97d3\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886872\uff1a<\/strong>\u97d3\u56fd\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886873\uff1a<\/strong>\u65e5\u672c\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886874\uff1a<\/strong>\u65e5\u672c\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886875\uff1a<\/strong>\u65e5\u672c\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886876\uff1a<\/strong>\u65e5\u672c\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886877\uff1a<\/strong>\u30a4\u30f3\u30c9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886878\uff1a<\/strong>\u30a4\u30f3\u30c9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886879\uff1a<\/strong>\u30a4\u30f3\u30c9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886880\uff1a<\/strong>\u30a4\u30f3\u30c9\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886881\uff1a<\/strong>\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886882\uff1a<\/strong>\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886883\uff1a<\/strong>\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886884\uff1a<\/strong>\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886885\uff1a<\/strong>\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886886\uff1a<\/strong>\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886887\uff1a<\/strong>\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886888\uff1a<\/strong>\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6700\u7d42\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886889\uff1a<\/strong>\u53f0\u6e7e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886890\uff1a<\/strong>\u53f0\u6e7e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08USD\u5341\u5104\uff09<\/li>\n<li><strong>\u886891\uff1a<\/strong>\u53f0\u6e7e\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886892\uff1a<\/strong>\u53f0\u6e7e\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886893\uff1a<\/strong>\u6771\u5357\u30a2\u30b8\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886894\uff1a<\/strong>\u6771\u5357\u30a2\u30b8\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886895\uff1a<\/strong>\u6771\u5357\u30a2\u30b8\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886896\uff1a<\/strong>\u6771\u5357\u30a2\u30b8\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886897\uff1a<\/strong>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886898\uff1a<\/strong>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u886899\uff1a<\/strong>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868100\uff1a<\/strong>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868101\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u56fd\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868102\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868103\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868104\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868105\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868106\uff1a<\/strong>UAE\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868107\uff1a<\/strong>UAE\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868108\uff1a<\/strong>UAE\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868109\uff1a<\/strong>UAE\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868110\uff1a<\/strong>\u30c8\u30eb\u30b3\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868111\uff1a<\/strong>\u30c8\u30eb\u30b3\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868112\uff1a<\/strong>\u30c8\u30eb\u30b3\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868113\uff1a<\/strong>\u30c8\u30eb\u30b3\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868114\uff1a<\/strong>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868115\uff1a<\/strong>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868116\uff1a<\/strong>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868117\uff1a<\/strong>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868118\uff1a<\/strong>\u5357\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868119\uff1a<\/strong>\u5357\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868120\uff1a<\/strong>\u5357\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868121\uff1a<\/strong>\u5357\u30a2\u30d5\u30ea\u30ab\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868122\uff1a<\/strong>\u30a8\u30b8\u30d7\u30c8\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868123\uff1a<\/strong>\u30a8\u30b8\u30d7\u30c8\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868124\uff1a<\/strong>\u30a8\u30b8\u30d7\u30c8\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868125\uff1a<\/strong>\u30a8\u30b8\u30d7\u30c8\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868126\uff1a<\/strong>\u30ca\u30a4\u30b8\u30a7\u30ea\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868127\uff1a<\/strong>\u30ca\u30a4\u30b8\u30a7\u30ea\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868128\uff1a<\/strong>\u30ca\u30a4\u30b8\u30a7\u30ea\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868129\uff1a<\/strong>\u30ca\u30a4\u30b8\u30a7\u30ea\u30a2\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868130\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868131\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868132\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868133\uff1a<\/strong>\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u306e\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868134\uff1a<\/strong>LATAM\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u56fd\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868135\uff1a<\/strong>LATAM\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff08\u7c73\u30c9\u30eb\u5341\u5104\uff09<\/li>\n<li><strong>\u8868136\uff1a<\/strong>LATAM\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868137\uff1a<\/strong>LATAM\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868138\uff1a<\/strong>LATAM\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868139\uff1a<\/strong>\u30d6\u30e9\u30b8\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868140\uff1a<\/strong>\u30d6\u30e9\u30b8\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868141\uff1a<\/strong>\u30d6\u30e9\u30b8\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868142\uff1a<\/strong>\u30d6\u30e9\u30b8\u30eb\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868143\uff1a<\/strong>\u30e1\u30ad\u30b7\u30b3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868144\uff1a<\/strong>\u30e1\u30ad\u30b7\u30b3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868145\uff1a<\/strong>\u30e1\u30ad\u30b7\u30b3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868146\uff1a<\/strong>\u30e1\u30ad\u30b7\u30b3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868147\uff1a<\/strong>\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868148\uff1a<\/strong>\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868149\uff1a<\/strong>\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868150\uff1a<\/strong>\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868151\uff1a<\/strong>\u30c1\u30ea\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868152\uff1a<\/strong>\u30c1\u30ea\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868153\uff1a<\/strong>\u30c1\u30ea\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868154\uff1a<\/strong>\u30c1\u30ea\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868155\uff1a<\/strong>\u30b3\u30ed\u30f3\u30d3\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868156\uff1a<\/strong>\u30b3\u30ed\u30f3\u30d3\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868157\uff1a<\/strong>\u30b3\u30ed\u30f3\u30d3\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868158\uff1a<\/strong>\u30b3\u30ed\u30f3\u30d3\u30a2\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868159\uff1a<\/strong>LATAM\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30bf\u30a4\u30d7\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868160\uff1a<\/strong>LATAM\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u6cbb\u7642\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868161\uff1a<\/strong>LATAM\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u85ac\u7406\u30af\u30e9\u30b9\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<li><strong>\u8868162\uff1a<\/strong>LATAM\u305d\u306e\u4ed6\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3068\u4e88\u6e2c\uff08\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\uff09 &#8211; 2022-2034\uff0810\u5104USD\uff09<\/li>\n<\/ul>\n<\/div>\n<\/ul>\n<p><\/h><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u6210\u9577\u3001\u4e88\u6e2c\uff082034\u5e74\u307e\u3067\uff09<\/p>\n<p>\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u306f\u30012025\u5e74\u306b67.2\u5104\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012026\u5e74\u306b\u306f71\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012034\u5e74\u306b\u306f109.7\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u898b\u8fbc\u307f\u3067\u3042\u308a\u30012026\u5e74\u304b\u30892034\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f5.6%\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u30022025\u5e74\u306b\u306f\u5317\u7c73\u304c\u814e\u764c\u85ac\u5e02\u5834\u309239.2%\u306e\u30b7\u30a7\u30a2\u3067\u652f\u914d\u3057\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n<p>\u814e\u764c\u85ac\u306f\u3001\u814e\u764c\uff08\u814e\u81d3\u764c\uff09\u3092\u6cbb\u7642\u3059\u308b\u305f\u3081\u306b\u7279\u5225\u306b\u958b\u767a\u3055\u308c\u305f\u533b\u85ac\u54c1\u3067\u3042\u308a\u3001\u624b\u8853\u3001\u653e\u5c04\u7dda\u7642\u6cd5\u3001\u514d\u75ab\u7642\u6cd5\u3068\u3068\u3082\u306b\u3001\u814e\u764c\u306e\u6cbb\u7642\u6226\u7565\u306e\u91cd\u8981\u306a\u90e8\u5206\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u904e\u53bb30\u5e74\u9593\u3067\u3001\u814e\u764c\u85ac\u5e02\u5834\u306f\u6cbb\u7642\u30d1\u30e9\u30c0\u30a4\u30e0\u306b\u5927\u304d\u306a\u5909\u5316\u3092\u9042\u3052\u3066\u304a\u308a\u3001\u73fe\u5728\u306f\u3088\u308a\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7d5e\u3063\u305f\u85ac\u5264\u3084\u514d\u75ab\u7642\u6cd5\u306b\u7126\u70b9\u304c\u5f53\u3066\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u751f\u6d3b\u7fd2\u6163\u306e\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u904b\u52d5\u4e0d\u8db3\u3001\u55ab\u7159\u3001\u98f2\u9152\u306e\u5897\u52a0\u304c\u5e02\u5834\u3092\u99c6\u52d5\u3057\u3066\u3044\u307e\u3059\u3002\u9ad8\u9f62\u5316\u793e\u4f1a\u306e\u9032\u5c55\u3084\u814e\u764c\u306e\u75c7\u4f8b\u5897\u52a0\u3082\u5e02\u5834\u306e\u62e1\u5927\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u5206\u6790\u671f\u9593\u4e2d\u3001\u814e\u764c\u85ac\u5e02\u5834\u306e\u30b7\u30a7\u30a2\u306f\u3001\u5f37\u529b\u306a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3068\u6025\u901f\u306b\u51fa\u73fe\u3059\u308b\u6cbb\u7642\u6cd5\u306b\u3088\u3063\u3066\u3055\u3089\u306b\u5f71\u97ff\u3092\u53d7\u3051\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u30bf\u30a4\u30d7\u5225\u306e\u6d1e\u5bdf<br \/>\n\u30af\u30ea\u30a2\u30bb\u30eb\u814e\u7d30\u80de\u764c\uff08ccRCC\uff09\u304c\u5e02\u5834\u30b7\u30a7\u30a2\u306e\u5927\u90e8\u5206\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002ccRCC\u306f\u814e\u7d30\u80de\u764c\u306e\u6700\u3082\u4e00\u822c\u7684\u306a\u30b5\u30d6\u30bf\u30a4\u30d7\u3067\u3042\u308a\u3001\u5168\u814e\u7d30\u80de\u764c\u306e\u7d0470-75%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u816b\u760d\u7d30\u80de\u306e\u7d30\u80de\u8cea\u304c\u900f\u660e\u307e\u305f\u306f\u6de1\u8272\u3067\u3042\u308a\u3001VHL\u907a\u4f1d\u5b50\u306e\u5909\u7570\u3068\u95a2\u9023\u3057\u3066\u3044\u307e\u3059\u3002ccRCC\u306f\u7279\u5b9a\u306e\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u306b\u5bfe\u3057\u3066\u826f\u597d\u306b\u53cd\u5fdc\u3057\u307e\u3059\u3002\u3053\u306e\u9ad8\u983b\u5ea6\u306b\u3088\u308a\u3001ccRCC\u30bb\u30af\u30bf\u30fc\u306f\u5e02\u5834\u306e\u652f\u914d\u7684\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3068\u3057\u3066\u6b8b\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30d1\u30d4\u30e9\u30ea\u30fc\u814e\u7d30\u80de\u764c\uff08pRCC\uff09\u306f\u3001\u5168\u814e\u7d30\u80de\u764c\u306e15-20%\u3092\u5360\u3081\u308b2\u756a\u76ee\u306b\u4e00\u822c\u7684\u306a\u30b5\u30d6\u30bf\u30a4\u30d7\u3067\u3059\u3002\u7d44\u7e54\u5b66\u7684\u7279\u6027\u306b\u57fa\u3065\u304d\u3001\u30bf\u30a4\u30d71\u3068\u30bf\u30a4\u30d72\u306b\u5206\u985e\u3055\u308c\u307e\u3059\u3002pRCC\u306f\u901a\u5e38\u3001ccRCC\u3088\u308a\u3082\u653b\u6483\u6027\u304c\u4f4e\u304f\u3001\u4e88\u5f8c\u304c\u826f\u597d\u3067\u3059\u3002<\/p>\n<p>\u6cbb\u7642\u30af\u30e9\u30b9\u306e\u6d1e\u5bdf<br \/>\n\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u304c\u5e02\u5834\u306e\u6700\u5927\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u306f\u3001\u764c\u7d30\u80de\u306e\u6210\u9577\u3068\u62e1\u6563\u306b\u95a2\u4e0e\u3059\u308b\u7279\u5b9a\u306e\u5316\u5b66\u7269\u8cea\u3084\u7d4c\u8def\u3092\u6a19\u7684\u306b\u3059\u308b\u533b\u85ac\u54c1\u306e\u4e00\u7a2e\u3067\u3059\u3002\u814e\u764c\u306b\u5bfe\u3059\u308b\u591a\u304f\u306e\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u306f\u3001\u8840\u7ba1\u65b0\u751f\uff08\u65b0\u3057\u3044\u8840\u7ba1\u306e\u751f\u6210\uff09\u3092\u6e1b\u5c11\u3055\u305b\u3001\u75c5\u6c17\u7279\u6709\u306e\u907a\u4f1d\u7684\u7570\u5e38\u3092\u6a19\u7684\u306b\u3057\u307e\u3059\u3002\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u306f\u764c\u7d30\u80de\u4e0a\u306e\u7279\u5b9a\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u3084\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3059\u308b\u3053\u3068\u3067\u3001\u7d30\u80de\u306e\u6210\u9577\u3068\u5206\u88c2\u3092\u6291\u5236\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u764c\u7d30\u80de\u3092\u3088\u308a\u6b63\u78ba\u306b\u6a19\u7684\u306b\u3059\u308b\u3053\u3068\u3067\u5065\u5eb7\u306a\u7d44\u7e54\u3078\u306e\u640d\u50b7\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u3002<\/p>\n<p>\u514d\u75ab\u7642\u6cd5\u306f\u3001\u4f53\u306e\u514d\u75ab\u7cfb\u3092\u5229\u7528\u3057\u3066\u764c\u7d30\u80de\u3092\u7279\u5b9a\u3057\u3001\u6a19\u7684\u306b\u3059\u308b\u533b\u85ac\u54c1\u306e\u30d5\u30a1\u30df\u30ea\u30fc\u3092\u6307\u3057\u307e\u3059\u3002\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u306f\u3001\u814e\u764c\u6cbb\u7642\u306b\u304a\u3044\u3066\u91cd\u8981\u6027\u3092\u5897\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u533b\u85ac\u54c1\u306f\u3001PD-1\u3084PD-L1\u306a\u3069\u306e\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u30d6\u30ed\u30c3\u30af\u3059\u308b\u3053\u3068\u3067\u3001\u764c\u7d30\u80de\u306b\u5bfe\u3059\u308b\u514d\u75ab\u53cd\u5fdc\u3092\u5236\u9650\u3057\u307e\u3059\u3002<\/p>\n<p>\u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u306e\u6d1e\u5bdf<br \/>\n\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u304c\u5e02\u5834\u306e\u6700\u5927\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u306f\u3001\u65b0\u3057\u3044\u8840\u7ba1\u306e\u751f\u6210\u3092\u59a8\u3052\u308b\u533b\u85ac\u54c1\u3067\u3042\u308a\u3001\u814e\u764c\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u6709\u52b9\u3067\u3059\u3002\u3053\u308c\u3089\u306e\u85ac\u5264\u306f\u4e3b\u306b\u816b\u760d\u5185\u306e\u8840\u7ba1\u65b0\u751f\u3092\u59a8\u3052\u3001\u8840\u6d41\u3068\u6804\u990a\u4f9b\u7d66\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u304c\u3001\u75b2\u52b4\u3001\u9ad8\u8840\u5727\u3001\u4e0b\u75e2\u306a\u3069\u306e\u526f\u4f5c\u7528\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>mTOR\uff08\u54fa\u4e73\u985e\u30e9\u30d1\u30de\u30a4\u30b7\u30f3\u6a19\u7684\uff09\u963b\u5bb3\u5264\u306f\u3001\u7d30\u80de\u306e\u6210\u9577\u3068\u5897\u6b96\u306e\u91cd\u8981\u306a\u8abf\u7bc0\u56e0\u5b50\u3067\u3042\u308bmTOR\u7d4c\u8def\u3092\u963b\u5bb3\u3059\u308b\u533b\u85ac\u54c1\u306e\u4e00\u7a2e\u3067\u3059\u3002\u3053\u308c\u3089\u306e\u963b\u5bb3\u5264\u306f\u814e\u764c\u306b\u304a\u3044\u3066\u3053\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u306b\u5e72\u6e09\u3057\u3001\u764c\u7d30\u80de\u306e\u5236\u5fa1\u3055\u308c\u306a\u3044\u767a\u5c55\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u3002<\/p>\n<p>\u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u306e\u6d1e\u5bdf<br \/>\n\u75c5\u9662\u3068\u30af\u30ea\u30cb\u30c3\u30af\u304c\u5e02\u5834\u6210\u9577\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u75c5\u9662\u3068\u30af\u30ea\u30cb\u30c3\u30af\u306f\u3001\u814e\u764c\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u533b\u7642\u65bd\u8a2d\u3067\u3042\u308a\u3001\u624b\u8853\u3001\u5316\u5b66\u7642\u6cd5\u3001\u653e\u5c04\u7dda\u7642\u6cd5\u3001\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u3084\u514d\u75ab\u7642\u6cd5\u306e\u63d0\u4f9b\u3092\u542b\u3080\u5e45\u5e83\u3044\u533b\u7642\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u75c5\u9662\u3068\u30af\u30ea\u30cb\u30c3\u30af\u306f\u3001\u814e\u764c\u60a3\u8005\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc\u306f\u3001\u5916\u6765\u624b\u8853\u3084\u6cbb\u7642\u3092\u5c02\u9580\u3068\u3059\u308b\u75c5\u9662\u3067\u3042\u308a\u3001\u814e\u764c\u306b\u304a\u3044\u3066\u306f\u814e\u751f\u691c\u3084\u6700\u5c0f\u4fb5\u8972\u624b\u8853\u3001\u7279\u5b9a\u306e\u6cbb\u7642\u306b\u5229\u7528\u3055\u308c\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5225\u306e\u6d1e\u5bdf<br \/>\n\u5317\u7c73\u306f\u4e16\u754c\u3067\u6700\u3082\u91cd\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u6301\u3061\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5065\u5168\u306aCAGR\u3067\u6210\u9577\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002\u5317\u7c73\u306f\u3001\u81e8\u5e8a\u5b9f\u8df5\u3001\u764c\u7814\u7a76\u3001\u764c\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u306e\u9032\u5c55\u306b\u3088\u308a\u3001\u814e\u764c\u85ac\u5e02\u5834\u3092\u652f\u914d\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30a2\u30e1\u30ea\u30ab\u764c\u5354\u4f1a\u306b\u3088\u308b\u3068\u30012018\u5e74\u306b\u306f\u7d0422,660\u4eba\u306e\u5973\u6027\u306842,680\u4eba\u306e\u7537\u6027\u304c\u814e\u764c\u3068\u8a3a\u65ad\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u5317\u7c73\u306b\u304a\u3051\u308b\u5e02\u5834\u6210\u9577\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u30a2\u30e1\u30ea\u30ab\u56fd\u7acb\u764c\u7814\u7a76\u6240\u306b\u3088\u308b\u3068\u3001ccRCC\u306f\u6210\u4eba\u306b\u304a\u3044\u3066\u6700\u3082\u4e00\u822c\u7684\u306a\u814e\u764c\u306e\u30bf\u30a4\u30d7\u3067\u3042\u308a\u3001\u814e\u7d30\u80de\u764c\u306e\u767a\u751f\u306e\u7d0480%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u6210\u4eba\u306f\u5b50\u4f9b\u3088\u308a\u3082ccRCC\u3092\u767a\u75c7\u3059\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u304f\u3001\u814e\u7d30\u80de\u764c\u306f\u5b50\u4f9b\u3084\u82e5\u5e74\u6210\u4eba\u306e\u814e\u764c\u306e\u5168\u767a\u751f\u306e2%\u304b\u30896%\u3092\u5360\u3081\u307e\u3059\u3002ccRCC\u306b\u5bfe\u3059\u308b\u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5\u306b\u306f\u3001\u30ab\u30dc\u30b6\u30f3\u30c1\u30cb\u30d6\u3001\u30a2\u30ad\u30b7\u30c1\u30cb\u30d6\u3001\u30b9\u30cb\u30c1\u30cb\u30d6\u3001\u30bd\u30e9\u30d5\u30a7\u30cb\u30d6\u3001\u30d1\u30be\u30d1\u30cb\u30d6\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u3053\u306e\u75c5\u6c17\u306e\u9ad8\u3044\u6709\u75c5\u7387\u3068\u8a3a\u65ad\u30c4\u30fc\u30eb\u3084\u6cbb\u7642\u30ec\u30b8\u30e1\u30f3\u306e\u5229\u7528\u53ef\u80fd\u6027\u306b\u3088\u308a\u3001\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306f\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30e8\u30fc\u30ed\u30c3\u30d1\u306e\u814e\u764c\u85ac\u5e02\u5834\u306e\u30c8\u30ec\u30f3\u30c9<br \/>\n\u30e8\u30fc\u30ed\u30c3\u30d1\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5065\u5168\u306aCAGR\u3092\u793a\u3059\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30b9\u30c8\u30ec\u30a4\u30c4\u30ea\u30b5\u30fc\u30c1\u306b\u3088\u308b\u3068\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u306f\u55ab\u7159\u3068\u30bf\u30d0\u30b3\u4f7f\u7528\u306e\u5897\u52a0\u306b\u3088\u308a\u3001\u4e8c\u756a\u76ee\u306b\u5927\u304d\u306a\u5e02\u5834\u3068\u306a\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002\u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30bf\u30d0\u30b3\u3068\u53e3\u8154\u5065\u5eb7\u306b\u95a2\u3059\u308b\u30d5\u30a1\u30af\u30c8\u30b7\u30fc\u30c8\uff082018\u5e74\uff09\u306b\u3088\u308b\u3068\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u306f\u6210\u4eba\u306e\u55ab\u7159\u7387\u304c28%\u3068\u6700\u3082\u9ad8\u3044\u5730\u57df\u3067\u3059\u3002\u3053\u306e\u5730\u57df\u306e\u30bf\u30d0\u30b3\u55ab\u7159\u306e\u9ad8\u3044\u6709\u75c5\u7387\u304c\u5e02\u5834\u306e\u62e1\u5927\u3092\u52a9\u3051\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3067\u306e\u814e\u764c\u306e\u767a\u751f\u7387\u306e\u4e0a\u6607\u3068\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u5229\u7528\u53ef\u80fd\u6027\u304c\u5e02\u5834\u6210\u9577\u306e\u6a5f\u4f1a\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30a4\u30ae\u30ea\u30b9\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u814e\u764c\u75c7\u4f8b\u6570\u306f\u30012023-2025\u5e74\u306b\u7d0416,300\u4ef6\u304b\u30892038-2040\u5e74\u306b\u306f\u7d0421,900\u4ef6\u306b\u5897\u52a0\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u30e8\u30fc\u30ed\u30c3\u30d1\u306e\u814e\u764c\u85ac\u5e02\u5834\u304c\u814e\u7d30\u80de\u764c\u6cbb\u7642\u3068\u7814\u7a76\u306b\u8ca2\u732e\u3059\u308b\u3053\u3068\u3092\u969b\u7acb\u305f\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u3001\u814e\u764c\u85ac\u5e02\u5834\u3067\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5730\u57df\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306f\u3001\u814e\u764c\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0\u3001\u30e9\u30a4\u30d5\u30b9\u30bf\u30a4\u30eb\u306e\u5909\u5316\u3001\u55ab\u7159\u7387\u306e\u4e0a\u6607\u306b\u3088\u308a\u62e1\u5927\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u53e3\u8154\u764c\u306e\u9ad8\u3044\u983b\u5ea6\u3082\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u62e1\u5927\u3092\u52a9\u3051\u3066\u3044\u307e\u3059\u3002\u56fd\u7acb\u751f\u7269\u5de5\u5b66\u60c5\u5831\u30bb\u30f3\u30bf\u30fc\u306b\u3088\u308b\u3068\u30012012\u5e74\u306b\u306f\u30a2\u30b8\u30a2\u8af8\u56fd\u3067121,099\u4ef6\u306e\u814e\u764c\u304c\u5831\u544a\u3055\u308c\u3066\u304a\u308a\u3001\u4eca\u5f8c\u6570\u5e74\u3067\u3053\u306e\u6570\u306f\u5897\u52a0\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u4e2d\u56fd\u3067\u306f\u300c\u5065\u5eb7\u4e2d\u56fd2020\u300d\u533b\u7642\u6539\u9769\u306e\u9032\u884c\u3068\u3059\u3079\u3066\u306e\u85ac\u5264\u30ab\u30c6\u30b4\u30ea\u306b\u304a\u3051\u308b\u4fa1\u683c\u5236\u9650\u306e\u64a4\u5ec3\u306b\u3088\u308a\u3001\u5e02\u5834\u62e1\u5927\u306e\u5927\u304d\u306a\u6a5f\u4f1a\u304c\u5b58\u5728\u3057\u307e\u3059\u3002\u4e2d\u56fd\u653f\u5e9c\u306f\u300112\u6b21\u4e94\u30ab\u5e74\u8a08\u753b\u306b\u304a\u3044\u3066\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u91cd\u8981\u306a\u6210\u9577\u7523\u696d\u3068\u3057\u3066\u5968\u52b1\u3059\u308b\u53d6\u308a\u7d44\u307f\u3092\u958b\u59cb\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u91cd\u8981\u306a\u672a\u5145\u8db3\u306e\u81e8\u5e8a\u30cb\u30fc\u30ba\u3092\u6301\u3064\u5927\u898f\u6a21\u306a\u30bf\u30fc\u30b2\u30c3\u30c8\u4eba\u53e3\u304c\u5730\u57df\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e2d\u6771\u3068\u30a2\u30d5\u30ea\u30ab\u306f\u3001\u4f4e\u3044\u533b\u7642\u652f\u51fa\u3001\u9650\u3089\u308c\u305f\u8a8d\u77e5\u5ea6\u3001\u7d4c\u6e08\u7684\u306b\u591a\u69d8\u306a\u56fd\u3005\u306e\u305f\u3081\u3001\u814e\u764c\u85ac\u5e02\u5834\u306e\u4e2d\u3067\u6700\u3082\u5c0f\u3055\u3044\u30b7\u30a7\u30a2\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u4e2d\u6771\u306b\u304a\u3051\u308b\u764c\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u306e\u62e1\u5145\u306b\u3088\u308a\u3001\u696d\u754c\u306f\u6210\u9577\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u814e\u764c\u85ac\u5e02\u5834\u306e\u4e3b\u8981\u4f01\u696d\u3068\u65b0\u8208\u4f01\u696d\u306e\u30ea\u30b9\u30c8<br \/>\n&#8211; \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9<br \/>\n&#8211; \u30d5\u30a1\u30a4\u30b6\u30fc<br \/>\n&#8211; \u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3<br \/>\n&#8211; \u30b8\u30a7\u30cd\u30f3\u30c6\u30c3\u30af<br \/>\n&#8211; \u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5<br \/>\n&#8211; \u30b7\u30d7\u30e9<br \/>\n&#8211; \u30a2\u30af\u30c6\u30a3\u30d6\u30fb\u30d0\u30a4\u30aa\u30c6\u30c3\u30af<br \/>\n&#8211; \u30a2\u30e0\u30b8\u30a7\u30f3<br \/>\n&#8211; \u30d0\u30a4\u30a8\u30eb<br \/>\n&#8211; \u30d6\u30ea\u30b9\u30c8\u30eb\u30fb\u30de\u30a4\u30e4\u30fc\u30ba \u30b9\u30af\u30a4\u30d6<\/p>\n<p>\u4e3b\u8981\u696d\u754c\u306e\u52d5\u5411<br \/>\n2026\u5e745\u6708\u3001\u30d5\u30a1\u30a4\u30b6\u30fc\u306f\u9032\u884c\u814e\u7d30\u80de\u764c\u306e\u305f\u3081\u306e\u4f75\u7528\u7642\u6cd5\u3092\u9032\u3081\u308b\u3053\u3068\u3067\u3001\u814e\u764c\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u81e8\u5e8a\u958b\u767a\u3092\u62e1\u5927\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7814\u7a76\u306f\u3001\u7121\u9032\u884c\u751f\u5b58\u671f\u9593\u3084\u6cbb\u7642\u7d50\u679c\u306e\u6539\u5584\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2026\u5e744\u6708\u3001\u30e1\u30eb\u30af\u306f\u9032\u884c\u814e\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308bKEYTRUDA\u00ae\u306e\u4f75\u7528\u7642\u6cd5\u306b\u95a2\u3059\u308b\u30dd\u30b8\u30c6\u30a3\u30d6\u306a\u81e8\u5e8a\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7d50\u679c\u306f\u3001\u5bfe\u8c61\u60a3\u8005\u306b\u304a\u3051\u308b\u6709\u52b9\u6027\u306e\u5411\u4e0a\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2026\u5e742\u6708\u3001\u30d6\u30ea\u30b9\u30c8\u30eb\u30fb\u30de\u30a4\u30e4\u30fc\u30ba\u30fb\u30b9\u30af\u30a4\u30d6\u306f\u814e\u764c\u306b\u5bfe\u3059\u308bOpdivo\u00ae\u30d9\u30fc\u30b9\u306e\u4f75\u7528\u7642\u6cd5\u306e\u7814\u7a76\u3092\u62e1\u5927\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u9577\u671f\u751f\u5b58\u7387\u306e\u5411\u4e0a\u3068\u6cbb\u7642\u30aa\u30d7\u30b7\u30e7\u30f3\u306e\u62e1\u5927\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2025\u5e7410\u6708\u3001\u30a8\u30af\u30bb\u30ea\u30af\u30b9\u306f\u9032\u884c\u814e\u7d30\u80de\u764c\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u7814\u7a76\u304b\u3089\u306eCABOMETYX\u00ae\u306e\u30dd\u30b8\u30c6\u30a3\u30d6\u306a\u66f4\u65b0\u3092\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u7d50\u679c\u306f\u3001\u8907\u6570\u306e\u6cbb\u7642\u8a2d\u5b9a\u3067\u306e\u4f7f\u7528\u62e1\u5927\u3092\u652f\u6301\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30ec\u30dd\u30fc\u30c8\u306e\u7bc4\u56f2<br \/>\n\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n&#8211; \u30bf\u30a4\u30d7\u5225<br \/>\n  &#8211; \u30af\u30ea\u30a2\u30bb\u30eb<br \/>\n  &#8211; \u30d1\u30d4\u30e9\u30ea\u30fc<br \/>\n  &#8211; \u30af\u30ed\u30e2\u30d5\u30a9\u30fc\u30d6<br \/>\n  &#8211; \u30aa\u30f3\u30b3\u30b5\u30a4\u30c6\u30a3\u30c3\u30af<br \/>\n  &#8211; \u96c6\u5408\u7ba1<br \/>\n  &#8211; \u305d\u306e\u4ed6<br \/>\n&#8211; \u6cbb\u7642\u30af\u30e9\u30b9\u5225<br \/>\n  &#8211; \u30bf\u30fc\u30b2\u30c3\u30c8\u7642\u6cd5<br \/>\n  &#8211; \u514d\u75ab\u7642\u6cd5<br \/>\n&#8211; \u85ac\u7406\u5b66\u7684\u30af\u30e9\u30b9\u5225<br \/>\n  &#8211; \u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264<br \/>\n  &#8211; mTOR\u963b\u5bb3\u5264<br \/>\n  &#8211; \u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<br \/>\n  &#8211; \u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u514d\u75ab\u7642\u6cd5\uff08IL-2\uff09<br \/>\n&#8211; \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225<br \/>\n  &#8211; \u75c5\u9662\u3068\u30af\u30ea\u30cb\u30c3\u30af<br \/>\n  &#8211; \u5916\u6765\u624b\u8853\u30bb\u30f3\u30bf\u30fc<br \/>\n  &#8211; \u8a3a\u65ad\u30bb\u30f3\u30bf\u30fc<br \/>\n  &#8211; \u7814\u7a76\u30bb\u30f3\u30bf\u30fc<br \/>\n  &#8211; \u305d\u306e\u4ed6<\/p>\n<p>\u30ab\u30d0\u30fc\u3055\u308c\u308b\u5730\u57df<br \/>\n&#8211; \u5317\u7c73<br \/>\n  &#8211; \u7c73\u56fd<br \/>\n  &#8211; \u30ab\u30ca\u30c0<br \/>\n&#8211; \u30e8\u30fc\u30ed\u30c3\u30d1<br \/>\n  &#8211; \u82f1\u56fd<br \/>\n  &#8211; \u30c9\u30a4\u30c4<br \/>\n  &#8211; \u30d5\u30e9\u30f3\u30b9<br \/>\n  &#8211; \u30b9\u30da\u30a4\u30f3<br \/>\n  &#8211; \u30a4\u30bf\u30ea\u30a2<br \/>\n  &#8211; \u30ed\u30b7\u30a2<br \/>\n  &#8211; \u5317\u6b27<br \/>\n  &#8211; \u30d9\u30cd\u30eb\u30af\u30b9<br \/>\n&#8211; \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<br \/>\n  &#8211; \u4e2d\u56fd<br \/>\n  &#8211; \u97d3\u56fd<br \/>\n  &#8211; \u65e5\u672c<br \/>\n  &#8211; \u30a4\u30f3\u30c9<br \/>\n  &#8211; \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<br \/>\n  &#8211; \u30b7\u30f3\u30ac\u30dd\u30fc\u30eb<br \/>\n  &#8211; \u53f0\u6e7e<br \/>\n  &#8211; \u6771\u5357\u30a2\u30b8\u30a2<br \/>\n&#8211; \u4e2d\u6771\u3068\u30a2\u30d5\u30ea\u30ab<br \/>\n  &#8211; UAE<br \/>\n  &#8211; \u30c8\u30eb\u30b3<br \/>\n  &#8211; \u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2<br \/>\n  &#8211; \u5357\u30a2\u30d5\u30ea\u30ab<br \/>\n  &#8211; \u30a8\u30b8\u30d7\u30c8<br \/>\n  &#8211; \u30ca\u30a4\u30b8\u30a7\u30ea\u30a2<br \/>\n&#8211; \u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab<br \/>\n  &#8211; \u30d6\u30e9\u30b8\u30eb<br \/>\n  &#8211; \u30e1\u30ad\u30b7\u30b3<br \/>\n  &#8211; \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<br \/>\n  &#8211; \u30c1\u30ea<br \/>\n  &#8211; \u30b3\u30ed\u30f3\u30d3\u30a2<\/p>\n<p>\u7af6\u4e89\u72b6\u6cc1<br \/>\n&#8211; \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9<br \/>\n&#8211; \u30d5\u30a1\u30a4\u30b6\u30fc<br \/>\n&#8211; \u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3<br \/>\n&#8211; \u30b8\u30a7\u30cd\u30f3\u30c6\u30c3\u30af<br \/>\n&#8211; \u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5<\/p>\n<p>\u7814\u7a76\u6210\u679c\u7269<br \/>\n\u53ce\u76ca\u4e88\u6e2c\u3001\u7af6\u4e89\u74b0\u5883\u3001\u6210\u9577\u8981\u56e0\u3001\u74b0\u5883\u304a\u3088\u3073\u898f\u5236\u306e\u52d5\u5411<\/p>\n<p>\u3088\u304f\u3042\u308b\u8cea\u554f\uff08FAQs\uff09<br \/>\n\u814e\u764c\u85ac\u5e02\u5834\u306e\u73fe\u5728\u306e\u4fa1\u5024\u306f\uff1f<br \/>\n\u814e\u764c\u85ac\u5e02\u5834\u306e\u898f\u6a21\u306f2026\u5e74\u306b71\u5104\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012034\u5e74\u306b\u306f109.7\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u898b\u8fbc\u307f\u3067\u30012026-2034\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u4e2d\u306eCAGR\u306f5.6%\u3067\u3059\u3002<\/p>\n<p>2025\u5e74\u306b\u814e\u764c\u85ac\u5e02\u5834\u3092\u652f\u914d\u3057\u305f\u5730\u57df\u306f\uff1f<br \/>\n2025\u5e74\u306b\u306f\u5317\u7c73\u304c39.2%\u306e\u30b7\u30a7\u30a2\u3067\u5e02\u5834\u3092\u652f\u914d\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u814e\u764c\u85ac\u5e02\u5834\u306e\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306f\u8ab0\u3067\u3059\u304b\uff1f<br \/>\n\u3053\u306e\u5e02\u5834\u306e\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306f\u30ce\u30d0\u30eb\u30c6\u30a3\u30b9\u3001\u30d5\u30a1\u30a4\u30b6\u30fc\u3001\u30b0\u30e9\u30af\u30bd\u30fb\u30b9\u30df\u30b9\u30af\u30e9\u30a4\u30f3\u3001\u30b8\u30a7\u30cd\u30f3\u30c6\u30c3\u30af\u3001\u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5\u3067\u3059\u3002<\/p>\n<p>\u814e\u764c\u85ac\u5e02\u5834\u306e\u6210\u9577\u7387\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<br \/>\n\u814e\u764c\u85ac\u5e02\u5834\u306f2026-2034\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u4e2d\u306bCAGR5.6%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/62468"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=62468"}],"version-history":[{"count":0,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/62468\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=62468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=62468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=62468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}